MedPath

SII-YFV

Generic Name
SII-YFV

A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL

Phase 3
Completed
Conditions
Yellow Fever
Interventions
First Posted Date
2022-06-16
Last Posted Date
2025-05-07
Lead Sponsor
Serum Institute of India Pvt. Ltd.
Target Recruit Count
1824
Registration Number
NCT05421611
Locations
🇰🇪

Victoria Biomedical Research Institute (VIBRI) - Kisumu County Referral Hospital, Kisumu, Kenya

🇰🇪

Kenya Medical Research Institute/ Centre for Research Disease Research (CRDR), Nairobi, Kenya

© Copyright 2025. All Rights Reserved by MedPath